BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bächinger D, Horvath L, Eckhard A, Goosmann MM, Honegger T, Gassmann M, Vogel J, Naldi AM. Neuronal erythropoietin overexpression is protective against kanamycin-induced hearing loss in mice. Toxicol Lett 2018;291:121-8. [PMID: 29654830 DOI: 10.1016/j.toxlet.2018.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hong H, Dooley KE, Starbird LE, Francis HW, Farley JE. Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment. Arch Toxicol 2019;93:1385-99. [PMID: 30963202 DOI: 10.1007/s00204-019-02407-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Jiang W, Peng A, Chen Y, Pang B, Zhang Z. Long non‑coding RNA EBLN3P promotes the recovery of the function of impaired spiral ganglion neurons by competitively binding to miR‑204‑5p and regulating TMPRSS3 expression. Int J Mol Med 2020;45:1851-63. [PMID: 32186779 DOI: 10.3892/ijmm.2020.4545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Sun C, Yao Y, Zhang C, Tong D, Xie B. EPO Attenuates Cisplatin-Induced Ototoxicity in HEI-OC1 Auditory Cell Via the Nrf2-ARE Signaling Pathway. Otology & Neurotology 2019;40:965-71. [DOI: 10.1097/mao.0000000000002288] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lin X, Luo J, Tan J, Yang L, Wang M, Li P. Experimental animal models of drug-induced sensorineural hearing loss: a narrative review. Ann Transl Med 2021;9:1393. [PMID: 34733945 DOI: 10.21037/atm-21-2508] [Reference Citation Analysis]